Latest Conference Articles

Managing the cognitive impairment in patients suffering from multiple sclerosis (MS), has long been an integral focus of MS research.

Francisco Sylvester, MD, UNC School of medicine emphasized the importance of applying study findings to early interventions in treatment.

Francisco A. Sylvester, MD, UNC School of Medicine talked about the different ways in which the care of pediatric IBD differs from adult IBD.

Peter Higgins, MD, PhD, University of Michigan Health System, talked about how patients these days are often answering their own nutritional questions on the "Wild Wild West" of the Internet, so it's up to the experts to provide thorough answers to assuage their concerns.

At the 2015 Advances in Inflammatory Bowel Diseases (AIBD) meeting in Orlando, Florida, Peter Higgins, MD, PhD, the University of Michigan Health System shared his insight about the importance and value of careful nutritional guidance for IBD patients.

It’s been suggested that probiotics can help prevent relapses in ulcerative colitis, but a new analysis presented in a poster session at the 2015 Advances in Inflammatory Bowel Diseases conference (AIBD 2015) in Orlando, Florida argues that that’s not the case.

Measures in place to limit systemic steroid use for patients with inflammatory bowel disease are not as effective as they need to be. They should be replaced by a two-part model to examine drug utilization patterns that would separately consider factors associated with initiation and duration of therapy.

Hospitalization and mortality is more likely in elderly patients with inflammatory bowel disease (IBD) when compared to their younger counterparts. With 5-aminosalicylates (5-ASA) and corticosteroids becoming more popular in this age group, it’s not clear how they affect patients in the long run.

Eva Szigethy, MD, PhD, University of Pittsburgh discussed at the 2015 Advances in Inflammatory Bowel Diseases (AIBD) how to continue the conversation and implement methods to treat the burgeoning concern of opioid dependence among pediatric IBD patients.

Study results show that patients with ulcerative colitis who undergo hematopoietic stem cell transplantation (HSCT) had higher rates of opportunistic infections and inpatient mortality compared to transplant patients who did not have UC.

Miguel Regueiro, MD, University of Pittsburgh Medical Center, highlighted the hot topics in IBD at the 2015 Advances in Inflammatory Bowel Diseases.

Researchers examined the possible connection between vitamin D levels and IBD in a cohort of African American patients with IBD and a control group of those patients’ African American healthy spouses and friends.

Fatigue is two to three times more likely to appear in patients with inflammatory bowel disease (IBD) than in healthy controls. Researchers from Østfold University College in Norway found that the common symptom can lead to additional interferences.

Russell Cohen, MD, director of the Inflammatory Bowel Diseases Center at The University of Chicago Medicine continued to discuss the relevance of healthcare economics specific to IBD at the 2015 Advances in Inflammatory Bowel Diseases.

Russell Cohen, MD, director of the Inflammatory Bowel Diseases Center at The University of Chicago Medicine, discussed the progress made not only in the clinical care of IBD, but also in the basic science group and translational core at the 2015 Advances in Inflammatory Bowel Diseases meeting in Orlando, FL.

Sometimes when a patient with epilepsy has a seizure they may not even recognize it for any number of reasons. A device no bigger than a piece of gum which is being developed could help in that effort going forward.

When epilepsy patients use marijuana their memory test results may not be accurate, researchers report.

There are many factors to consider when treating patients with epilepsy, from the number of medications they take to the impact of the condition on their daily lives. All these factors can help determine their overall quality of life.

There are many factors to consider when treating patients with epilepsy, from the number of medications they take to the impact of the condition on their daily lives. All these factors can help determine their overall quality of life.

Barbara Cappelli, MD, Eurocord International Registry, Paris, France, shared an overview from her team's study that found further evidence that for patients with severe sickle cell disease who have an HLA-identical sibling available as a donor, HSCT can be safe and effective.

Tetramethylenedisulfotetramine, a banned yet still available rat poison, is considered a potential terrorist weapon, largely because there is no specific antidote. Poisoning causes status epilepticus and death. Perampanel may be an antidote, researchers found.

Focal epilepsy is just one form of the condition which can affect patients of all ages. Recent research into what may cause the condition and what can be done to treat it focused on a gene known as CLOCK.

Mitchell Smith, MD, Cleveland Clinic shared highlights of his team's posters and discussed the progression of immunotherapies at the 57th American Society of Hematology Annual Meeting.

Epileptic seizures that go on for 30 minutes or more put children in mortal danger. Researchers report on promising treatments, and ones that appear ineffective.

A new treatment option for deep vein thrombosis (DVT) and pulmonary embolism (PE) was recently introduced, but it looks like old habits die hard when it comes to prescriptions.

Ventricular assist devices (VADs) are literally life savers for some patients with heart failure, however, the technology can be accompanied by serious risks.

Brian Bolwell, MD, Cleveland Clinic, discussed how all the information they're finding out about myeloid malignancies is very important, but also complex so making broad statements is challenging.

The phase three studies, B-LONG and Kids B-LONG, examined outcomes with a hemophilia B therapy in adults and adolescents. Now an extension study went further to verify the findings and the results were presented at the 57th American Society of Hematology Annual Meeting (ASH 2015) in Orlando, Florida.

MRI scans of patients with intractable epilepsy showed their brains age prematurely, a study found. These patients' brains looked almost 9 years older than they really were.

Cannabidiol-a marijuana plant extract that does not have psychoactive effects-is showing promise in treatment-resistant forms of epileps